Invenomic Capital Management LP Mckesson Corp Transaction History

Invenomic Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$244.61 - $310.48 $7.76 Million - $9.84 Million	-31,705 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$198.21 - $248.9 $2.11 Million - $2.65 Million	10,637 Added 50.49%	31,705 $7.88 Million
Q3 2021 Nov 15, 2021	BUY	$188.42 - $208.66 $3.97 Million - $4.4 Million	21,068 New	21,068 $4.2 Million
Q3 2020 Nov 13, 2020	SELL	$140.89 - $159.9 $244,725 - $277,746	-1,737 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$125.49 - $164.68 $217,976 - $286,049	1,737 New	1,737 $266,000

1,690

109M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $90.3B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Invenomic Capital Management LP with notifications on news.